Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02468804 · ClinicalTrials.gov registry record · NA
Cognitive Dysfunction In Parkinson's
A NA study of Parkinsons, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT02468804: Completed NA study of Parkinsons, sponsored by University of Colorado, Denver.
NCT02468804 is a NA study of Parkinsons that has completed, run by University of Colorado, Denver. The registered enrollment target is 107 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02468804, a NA study of Parkinsons, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
We hypothesize that reductions in gamma activity are a key mechanism underlying cognitive dysfunction in PD and that interventions to increase gamma activity will improve cognition.
Primary Outcome
The primary cognitive outcome will be the error rates on the N-back task measured before and after real or sham TMS as a measure of working memory. A negative number indicates that error rate was higher (working memory skills were worse) in the sham than the real condition. A positive number indicates lower error rates (better working memory skills) in the sham vs real stimulation.
Conditions Studied
Interventions
- DEVICE rTMS
- DEVICE Sham TMS
Study Locations (1)
Colorado
- UC Denver Building 534 - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT02468804 record still lists
NCT02468804 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Parkinsons appearing as the primary indexed condition, and to 2 interventions - of which rTMS is the first listed.
NCT02468804 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02468804 about?
NCT02468804 is a clinical study titled "Cognitive Dysfunction In Parkinson's". We hypothesize that reductions in gamma activity are a key mechanism underlying cognitive dysfunction in PD and that interventions to increase gamma activity will improve cognition.
What is the current status of trial NCT02468804?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2013-08. Estimated completion is 2016-11.
What conditions does trial NCT02468804 study?
This clinical trial studies the following conditions: Parkinsons.
What interventions are being tested in trial NCT02468804?
The interventions under investigation include: rTMS (DEVICE), Sham TMS (DEVICE).
Who is sponsoring clinical trial NCT02468804?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02468804 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02468804's enrollment target sits among peer trials
107 830th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia